Cell therapy manufacturing is shifting to automated, closed systems and CDMO outsourcing, creating opportunities in GMP capacity, allogeneic platforms, equipment, consumables and logistics.Dublin, ...
Watch Yahoo Finance's streaming coverage for real-time market news, analysis, and expert commentary throughout the day to help you make smarter money decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results